GT Biopharma Inc (GTBP)
2.95
-0.02
(-0.67%)
USD |
NASDAQ |
Nov 04, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Price: 2.95 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 2.95 | 3.00 | 2.88 | 2.97 | 3875.00 |
| Oct 31, 2024 | 2.97 | 3.01 | 2.85 | 2.94 | 13491.00 |
| Oct 30, 2024 | 3.229 | 3.295 | 3.01 | 3.01 | 15192.00 |
| Oct 29, 2024 | 3.23 | 3.37 | 3.10 | 3.33 | 15751.00 |
| Oct 28, 2024 | 3.192 | 3.30 | 3.008 | 3.30 | 22812.00 |
| Oct 25, 2024 | 3.000 | 3.12 | 2.92 | 3.12 | 44103.00 |
| Oct 24, 2024 | 3.02 | 3.545 | 2.80 | 3.02 | 79460.00 |
| Oct 23, 2024 | 2.54 | 2.96 | 2.54 | 2.949 | 47242.00 |
| Oct 22, 2024 | 2.43 | 2.56 | 2.43 | 2.54 | 39538.00 |
| Oct 21, 2024 | 2.29 | 2.575 | 2.260 | 2.42 | 37178.00 |
| Oct 18, 2024 | 2.11 | 2.34 | 2.037 | 2.29 | 22473.00 |
| Oct 17, 2024 | 2.02 | 2.17 | 2.015 | 2.11 | 27172.00 |
| Oct 16, 2024 | 1.97 | 2.000 | 1.97 | 2.00 | 16936.00 |
| Oct 15, 2024 | 2.005 | 2.04 | 1.950 | 1.99 | 8659.00 |
| Oct 14, 2024 | 2.02 | 2.049 | 2.00 | 2.049 | 4598.00 |
| Oct 11, 2024 | 2.00 | 2.08 | 2.00 | 2.05 | 11434.00 |
| Oct 10, 2024 | 2.01 | 2.085 | 2.00 | 2.00 | 12021.00 |
| Oct 09, 2024 | 2.06 | 2.18 | 2.05 | 2.07 | 21193.00 |
| Oct 08, 2024 | 2.095 | 2.12 | 2.060 | 2.085 | 1913.00 |
| Oct 07, 2024 | 1.97 | 2.142 | 1.97 | 2.065 | 11428.00 |
| Oct 04, 2024 | 2.145 | 2.18 | 1.95 | 2.02 | 30165.00 |
| Oct 03, 2024 | 2.120 | 2.186 | 2.10 | 2.103 | 11434.00 |
| Oct 02, 2024 | 2.06 | 2.191 | 2.06 | 2.15 | 13909.00 |
| Oct 01, 2024 | 2.311 | 2.550 | 2.20 | 2.22 | 24098.00 |
| Sep 30, 2024 | 2.13 | 2.80 | 2.100 | 2.309 | 65111.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.95
Minimum
Sep 06 2024
568.80
Maximum
Jun 02 2021
91.33
Average
66.90
Median
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.78 |
| Palatin Technologies Inc | 1.20 |
| iBio Inc | 2.66 |
| Theriva Biologics Inc | 2.08 |
| Oragenics Inc | 0.3089 |
Price Related Metrics
| PS Ratio | 69.01 |
| Price to Book Value | 1.197 |
| Earnings Yield | -257.4% |
| Market Cap | 6.591M |